However, better differentiated cells may also require its activity, and additional studies will be required to determine the precise contribution of ZNF521 to medulloblastoma pathogenesis and its potential utility as a candidate target for advanced therapeutic approaches in MB-initiating cells. The gene discussed is ZNF521; the disease is medulloblastoma.